Arabic Arabic English English French French German German
dark

New therapeutic molecule yields new hope for Duchenne muscular dystrophy patients

A research team led by Nicolas Dumont, a researcher at CHU Sainte-Justine and professor at the Université de Montréal, has discovered a new therapeutic molecule, Resolvin-D2. It has the potential to significantly improve the quality of life of patients with Duchenne muscular dystrophy (DMD) by stimulating muscle stem-cell activity. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Researchers discover new type of nerve cell in the retina

Next Post

Former Education Secretary DeVos’ Family Invested in Theranos

Related Posts
Total
0
Share